Early detection of early-stage lung cancer with a blood test? A study in @BioMedCentral has shown that #LCDT1 blood test exhibited high accuracy in detecting Stage I #NSCLC with 95.6% accuracy, 89.1% sensitivity, and 97.7% specificity on the blind set. ht
A study in @BioMedCentral (Part of @SpringerNature) has shown that #LCDT1 blood test exhibited 95.6% accuracy, 89.1% sensitivity, and 97.7% specificity in detecting Stage I #NSCLC on the blind set. https://t.co/wBWJ9kIAK9 #LCSM #LungCancerResearch #Cancer
According to a recent study published in @BioMedCentral, TargetDx Laboratory's #LCDT1 blood test exhibited high accuracy (>95%) in detecting Stage I #NSCLC. https://t.co/wBWJ9kIAK9 Learn more about LCDT1 here: https://t.co/Im4olYy2xv #LCSM #LungCancer
According to a recent study, #LCDT1 blood test exhibited high accuracy in detecting Stage I Non-Small Cell #lungcancer (#NSCLC) with 95.6% accuracy, 89.1% sensitivity, and 97.7% specificity. Learn more: https://t.co/wBWJ9kIAK9 #Pulmonology #Bronchoscopy